Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.

by Claudia Grosse, Alex Soltermann, Markus Rechsteiner, Alexandra Grosse
Published 2019-01-01

Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland

by Alexandra Grosse, Claudia Grosse, Markus Rechsteiner, Alex Soltermann
Published 2019-02-01

Pleomorphic lobular breast carcinoma with osteoclast like giant cells in the era of genomic testing

by Uwe Güth, Ana Borovecki, Esther Amann, Markus Rechsteiner, Marianne Tinguely
Published 2020-12-01

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

by Christian Britschgi, Alfredo Addeo, Markus Rechsteiner, Raphaël Delaloye, Martin Früh, Martin Früh, Giulio Metro, Marco Banini, Oliver Gautschi, Sacha I. Rothschild, Peter J. Wild, Giuseppe L. Banna, Alessandra Curioni-Fontecedro
Published 2020-08-01

Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer

by Niels J Rupp, Peter J Schuffler, Qing Zhong, Florian Falkner, Markus Rechsteiner, Jan H Ruschoff, Christian Fankhauser, Matthias Drach, Remo Largo, Mathias Tremp, Cedric Poyet, Tullio Sulser, Glen Kristiansen, Holger Moch, Joachim Buhmann, Michael Muntener, Peter J Wild
Published 2016-01-01

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

by Joanna Mangana, Phil F Cheng, Katja Schindler, Benjamin Weide, Ulrike Held, Anna L Frauchiger, Emanuella Romano, Katharina C Kähler, Sima Rozati, Markus Rechsteiner, Holger Moch, Olivier Michielin, Claus Garbe, Axel Hauschild, Christoph Hoeller, Reinhard Dummer, Simone M Goldinger
Published 2015-01-01